The SOP, Investigator-Initiated Multi-Site Trial Management, has been updated (version 5, effective 12 September 2022). The key change includes:

• Inclusion of procedures required when changing from a previously approved single site trial to a Stanford-led multi-site trial (Section 5.4).

If this is applicable to your work, please review this updated SOP as soon as possible at https://med.stanford.edu/ccto/services/regulatory.html#sops and attest to your mastery of the information in the SOP confirmation form available on the same webpage.